Trial · NCT02195583
Adverse events84
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 84
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Oral Mucosal Erythema | Gastrointestinal disorders | Sodium Fluoride (1426 Ppm) | 2 | 59 | |
| other | Oral Mucosal Erythema | Gastrointestinal disorders | Sodium Fluoride (1150 Ppm) | 0 | 57 | |
| other | Oral Mucosal Erythema | Gastrointestinal disorders | Sodium Fluoride (250 Ppm) | 0 | 55 | |
| other | Oral Mucosal Erythema | Gastrointestinal disorders | Sodium Fluoride (1426 Ppm) + Zinc Base A | 0 | 58 | |
| other | Oral Mucosal Erythema | Gastrointestinal disorders | Sodium Fluoride (1426 Ppm) + Zinc Base B | 1 | 60 | |
| other | Oral Mucosal Erythema | Gastrointestinal disorders | Sodium Fluoride (0 Ppm) | 2 | 59 | |
| other | Abdominal Discomfort | Gastrointestinal disorders | Sodium Fluoride (1426 Ppm) | 0 | 59 | |
| other | Abdominal Discomfort | Gastrointestinal disorders | Sodium Fluoride (1150 Ppm) | 0 | 57 | |
| other | Abdominal Discomfort | Gastrointestinal disorders | Sodium Fluoride (250 Ppm) | 1 | 55 | |
| other | Abdominal Discomfort | Gastrointestinal disorders | Sodium Fluoride (1426 Ppm) + Zinc Base A | 0 | 58 | |
| other | Abdominal Discomfort | Gastrointestinal disorders | Sodium Fluoride (1426 Ppm) + Zinc Base B | 0 | 60 | |
| other | Abdominal Discomfort | Gastrointestinal disorders | Sodium Fluoride (0 Ppm) | 0 | 59 | |
| other | Parotid Gland Enlargement | Gastrointestinal disorders | Sodium Fluoride (1426 Ppm) | 0 | 59 | |
| other | Parotid Gland Enlargement | Gastrointestinal disorders | Sodium Fluoride (1150 Ppm) | 0 | 57 | |
| other | Parotid Gland Enlargement | Gastrointestinal disorders | Sodium Fluoride (250 Ppm) | 0 | 55 | |
| other | Parotid Gland Enlargement | Gastrointestinal disorders | Sodium Fluoride (1426 Ppm) + Zinc Base A | 0 | 58 | |
| other | Parotid Gland Enlargement | Gastrointestinal disorders | Sodium Fluoride (1426 Ppm) + Zinc Base B | 1 | 60 | |
| other | Parotid Gland Enlargement | Gastrointestinal disorders | Sodium Fluoride (0 Ppm) | 0 | 59 | |
| other | Nasopharyngitis | Infections and infestations | Sodium Fluoride (1426 Ppm) | 0 | 59 | |
| other | Nasopharyngitis | Infections and infestations | Sodium Fluoride (1150 Ppm) | 0 | 57 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02195583/events